Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Ligufalimab (anti-CD47) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab (anti-CD47) does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab (anti-CD47) shows anti-tumor activity.
Ligufalimab (anti-CD47) (Ab191922) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD47 with Ligufalimab (anti-CD47) (Ab191922) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Ligufalimab (anti-CD47) (Ab191922) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD47 (red) with Ligufalimab (anti-CD47) (Ab191922) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Ligufalimab (anti-CD47) (Ab191922) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling CD47 (red) with Ligufalimab (anti-CD47) (Ab191922) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Ligufalimab (anti-CD47) (Ab191922) - ELISA
Immobilized Recombinant Human CD47 protein (rp144028) at 1.0 μg/mL can bind Ligufalimab (anti-CD47) (Ab191922) with the EC₅₀ of 15.29 ng/mL.
Ligufalimab (anti-CD47) (Ab191922) - SEC
The purity of Ligufalimab (anti-CD47) (Ab191922) is more than 95% verified by HPLC.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →
